2. Protein Tyrosine Kinase/RTK Apoptosis
  3. VEGFR Apoptosis
  4. Anti-Mouse VEGFR-2 Antibody (DC101)

Anti-Mouse VEGFR-2 Antibody (DC101) 

製品番号: HY-P990106 純度: 99%
COA Technical Support

Anti-Mouse VEGFR-2 Antibody (DC101) is a rat anti-mouse VEGFR2 monoclonal antibody. Anti-Mouse VEGFR-2 Antibody (DC101) inhibits tumor angiogenesis by blocking the binding of VEGF and VEGFR2. Anti-Mouse VEGFR-2 Antibody (DC101) promotes immune cell infiltration and induces tumor cell apoptosis. Anti-Mouse VEGFR-2 Antibody (DC101) can be used for researches on various types of cancer such as melanoma, lung cancer and breast cancer .

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

容量 価格（税別） 在庫状況 数量
>無料サンプル (100 μg)   今すぐ申し込む  
1 mg $90 在庫あり
5 mg $320 在庫あり
10 mg $545 在庫あり
50 mg   お問い合わせ  
100 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 0 publication(s) in Google Scholar

Anti-Mouse VEGFR-2 Antibody (DC101) Featured Recommendations:

Anti-Mouse VEGFR-2 Antibody (DC101) 関連抗体

Top Publications Citing Use of Products

VEGFR アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
VEGFR1/Flt-1 VEGFR2/KDR/Flk-1 VEGFR3/Flt-4

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Anti-Mouse VEGFR-2 Antibody (DC101) is a rat anti-mouse VEGFR2 monoclonal antibody. Anti-Mouse VEGFR-2 Antibody (DC101) inhibits tumor angiogenesis by blocking the binding of VEGF and VEGFR2. Anti-Mouse VEGFR-2 Antibody (DC101) promotes immune cell infiltration and induces tumor cell apoptosis. Anti-Mouse VEGFR-2 Antibody (DC101) can be used for researches on various types of cancer such as melanoma, lung cancer and breast cancer [1][2][3][4][5][6].

Isotype

Rat IgG1 kappa
Recommend Isotype Controls
Species Reactivity

Mouse
IC50 & Target[1][2][3][4][5][6]

VEGFR2

 

体内実験

Anti-Mouse VEGFR-2 Antibody (DC101) (1 mg/dose, i.p., twice weekly, for 4 weeks) significantly induces apoptosis of tumor cells and endothelial cells, and significantly inhibits angiogenesis in male athymic BALB/c nude mice bearing 253J B-V tumors[1].
Anti-Mouse VEGFR-2 Antibody (DC101) (10 mg/kg, i.p., on day 2, 5 and 8) significantly inhibits tumor growth without significant toxicity in female BALB/c mice bearing H22 tumors[2].
Anti-Mouse VEGFR-2 Antibody (DC101) (40 mg/kg, i.g., once every three days, for 4 weeks) significantly inhibits tumor growth and increases immune cell infiltration in female C57BL/6 mice bearing B16-OVA tumors[3].
Anti-Mouse VEGFR-2 Antibody (DC101) (40 mg/kg, i.p., three times every week, for 21 days) significantly inhibits wound induced tumors in transgenic mice expressing CER of HPV8[4].
Anti-Mouse VEGFR-2 Antibody (DC101) (0.8 mg/mouse, i.p., twice weekly, for 2-3 weeks) inhibits tumor growth and increases T cell infiltration in FVB mice and Neu-N mice bearing NT2.5 tumors[5].
Anti-Mouse VEGFR-2 Antibody (DC101) (100 or 400 μg, i.p., once every three days, for 21 days) significantly reduces angiogenesis and endothelial cell count in female C57BL/6 mice injected with bFGF and VEGF[6].
Anti-Mouse VEGFR-2 Antibody (DC101) (800 μg, i.p., once every three days) significantly inhibits the growth of various tumors[6].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 1×106 253J B-V cells injected male athymic BALB/c nude mice (8-12 weeks)[1]
Dosage: 1 mg/dose, combined with Paclitaxel (HY-B0015) 10 mg/kg
Administration: Intraperitoneal injection (i.p.), twice weekly for 4 weeks
Result: Significantly prolonged the survival period of mice.
Significantly reduced tumor microvascular density.
Enhanced apoptosis of tumor cells and endothelial cells.
Animal Model: 2×106 H22 cells injected female BALB/c mice (6-8 weeks, 20 g)[2]
Dosage: 10 mg/kg, combined with CA4 NPs (45 mg/kg) and anti-PD-1 (100 μg/mouse)
Administration: Intraperitoneal injection (i.p.) on day 2, 5 and 8
Result: Increased the number of CD8+ T cells within the tumor.
Significantly improved vascular perfusion.
Reduced the level of IFN-γ and TNF-α.
Had good safety in vivo.
Animal Model: 5×105 B16-OVA cells injected female C57BL/6 mice (6-8 weeks)[3]
Dosage: 40 mg/kg
Administration: Oral gavage (i.g.), once every three days for 4 weeks
Result: Significantly inhibited tumor volume.
Increased infiltration of CD3+ and CD8+ T cells.
Increased infiltration of B cells (CD19+) and dendritic cells (CD11c+).
Enhanced the expression of IFN-γ, perforin, and granzyme B in CD8+ T cells.
Reduced vascular density and increased perivascular cell coverage.
Significantly increased the density of PNAd+HEV and promoted the formation of tertiary lymphoid structures (TLS).
Upregulated PD-L1 expression in tumor cells and CD45+ immune cells, as well as PD-1 expression in CD3+ T cells.
Animal Model: Transgenic mice expressing CER of HPV8[4]
Dosage: 40 mg/kg
Administration: Intraperitoneal injection (i.p.), three times every week for 21 days
Result: Reduced Ki-67+ proliferating cells and CD31+ vascular density.
Animal Model: 5×106 NT2.5 cells injected FVB mice and Neu-N mice[5]
Dosage: 0.8 mg/mouse
Administration: Intraperitoneal injection (i.p.), twice weekly for 2-3 weeks
Result: Increased CD4+ and CD8+ T cell infiltration.
Significantly inhibited tumor volume.
Decreased angiogenesis and increased tumor cell apoptosis.
Animal Model: Female C57BL/6 injected with bFGF (500 ng) and VEGF (10 μg)[6]
Dosage: 100 or 400 μg
Administration: Intraperitoneal injection (i.p.), once every three days for 21 days
Result: Significantly reduced angiogenesis and endothelial cell count in matrigel plug model.
Animal Model: 2×106 Lewis lung cells or 1×105 B16 cells injected female C57BL/6 mice (5-6 weeks), 1×105 4T1 cells injected female BALB/c mice (5-6 weeks), 2×106 A431, SK-RC-29, BxPC-3 or GBM-18 cells injected female athymic nu/nu mice (5-6 weeks)[6]
Dosage: 800 μg
Administration: Intraperitoneal injection (i.p.), once every three days
Result: Significantly inhibited tumor growth.
Gene ID

16542  [NCBI]

Accession
Application

ELISA, FACS, Functional assay, Research in vivo
Conjugated

Unconjugated
Reconsititution

The product can be reconstituted/diluted with sterile PBS or saline.
分子量

150 kDa

Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Anti-Mouse VEGFR-2 Antibody (DC101)]
Formulation

Please refer to the lot-specific COA for specific buffer information.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
  • Immobilized VEGFR-2/Flk-1/KDR Fc Chimera Protein, Mouse can bind Anti-Mouse VEGFR-2 Antibody (DC101). The EC50 for this effect is 177.8 ng/mL.
純度とドキュメンテーション

純度: 99.41%

COA (232 KB) SDS-PAGE (84 KB) SEC-HPLC (218 KB)

Inhibitory Antibodies User Guide (603 KB)
参考文献
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Anti-Mouse VEGFR-2 Antibody (DC101) Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Anti-Mouse VEGFR-2 Antibody (DC101)VEGFRApoptosisVascular endothelial growth factor receptorVEGFR2apoptosismelanomalung cancerprostate cancerbreast cancerhepatocellular carcinomaInhibitorinhibitorinhibit

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

  

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

      

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Anti-Mouse VEGFR-2 Antibody (DC101)
製品番号:
HY-P990106
数量:
MCE 日本正規代理店:

カスタマーレビュー

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

製品名

  

Lot #

お名前 *

 

メールアドレス *

電話番号 *

 

部門 *

組纖名 *

 

国或いは地域 *

備考

Request for HNMR Report

We have received your request and will respond to you as soon as possible.